Ilyas K. Colombowala, MD, FACC, FHRS
Cardiac Electrophysiology · Houston, TX · colombowala.com

Emergency

Contrast Reaction

Iodinated contrast reactions span a wide spectrum — from mild urticaria to anaphylactic shock. Most are mild and self-limited; some need IM epinephrine and full anaphylaxis management. Premedication protocols matter for patients with known history; recognition matters for the rest.

Indications

  • New onset rash, urticaria, nausea, bronchospasm, or hemodynamic change after contrast administration
  • Patient with known prior contrast reaction undergoing repeat exposure
  • Severe systemic reaction during or shortly after a contrast-enhanced case

Equipment / drugs

  • Diphenhydramine 25–50 mg IV (mild reactions, adjunct in moderate)
  • Methylprednisolone 125 mg IV or hydrocortisone 100 mg IV (moderate/severe, biphasic prevention)
  • Epinephrine 1:1000 (IM) — 0.3–0.5 mg for anaphylactoid/anaphylactic reactions
  • Albuterol nebulizer for bronchospasm
  • IV fluids ready for shock management
  • Stocked premedication regimen for known-allergy patients

Pitfalls

  • Treating all contrast reactions as anaphylaxis — over-treatment of mild reactions is its own complication
  • Treating anaphylactoid contrast reactions with diphenhydramine alone — needs epinephrine if hemodynamic compromise or bronchospasm
  • Premedicating an unstable patient who needs urgent contrast — premedication does not reliably prevent reactions; do not delay urgent care
  • Missing the difference between contrast nephropathy and contrast allergy — different mechanisms, different management
  • Forgetting to document the agent name and reaction severity in the allergy band

Two distinct problems sharing a name

“Contrast reaction” actually covers two unrelated mechanisms that are sometimes confused:

  1. Allergic/anaphylactoid reactions — immune-mediated or pseudo-allergic, involving mast cell degranulation; range from urticaria to anaphylactic shock. This page is about these.
  2. Contrast-induced nephropathy — acute kidney injury related to contrast volume and patient risk factors; different mechanism, different management. Mentioned briefly at the end.

When a patient says “I’m allergic to contrast,” they usually mean the first kind. When the nephrologist talks about “contrast reaction,” they often mean the second.

Recognizing the allergic spectrum

Allergic contrast reactions fall into three severity tiers. The grading determines what you do.

Mild reactions

  • Limited urticaria or rash
  • Mild itching
  • Nausea or single episode of emesis
  • Transient mild flushing or warmth
  • Stable vital signs

Treatment: typically nothing. Observe and reassure. If pruritus is bothersome, diphenhydramine 25–50 mg IV. Most resolve in 15–60 minutes.

Moderate reactions

  • Extensive urticaria
  • Persistent vomiting
  • Mild bronchospasm (wheeze without hypoxia or significant work of breathing)
  • Facial edema without airway compromise
  • Vasovagal-appearing reaction (bradycardia + hypotension, briefly)

Treatment:

  • Diphenhydramine 25–50 mg IV
  • Famotidine 20 mg IV (H2 add-on improves response)
  • Methylprednisolone 125 mg IV — to reduce risk of biphasic recurrence
  • Albuterol nebulized 5 mg if bronchospasm
  • Monitor for several hours; do not discharge from the lab immediately

Severe reactions (anaphylactoid/anaphylactic)

  • Hypotension
  • Severe bronchospasm with hypoxia
  • Airway edema, stridor, voice change
  • Cardiovascular collapse
  • Loss of consciousness

Treatment: identical to anaphylaxis. See anaphylaxis for the detailed protocol.

  • IM epinephrine 0.3–0.5 mg into the lateral mid-thigh — FIRST move
  • Stop the contrast immediately
  • Call for help — anesthesia, code team
  • IV fluid resuscitation — 1–2 L crystalloid wide open
  • Supplemental oxygen, BVM if needed
  • Antihistamines + steroid in parallel
  • Repeat IM epinephrine every 5–15 minutes if not responding
  • IV epinephrine infusion for refractory shock
  • Monitor and observe for biphasic recurrence — minimum 4–8 hours, longer for severe

Allergic vs anaphylactoid — does it matter?

Technically, true allergic reactions involve IgE-mediated mast cell degranulation, while “anaphylactoid” reactions involve direct (non-IgE) mast cell triggering by contrast molecules. Treatment is identical in the acute setting. The distinction matters mainly for prevention — true IgE allergies will recur with the same agent every time; anaphylactoid reactions are unpredictable and may be tolerable on premedication.

For practical purposes in the lab: treat what’s in front of you; figure out the mechanism later.

Premedication for known-allergy patients

Patients with a known prior contrast reaction undergoing a procedure where contrast is needed: premedication reduces the severity of recurrent reactions but does NOT reliably prevent them.

Standard outpatient regimen (planned procedures)

  • Prednisone 50 mg PO at 13, 7, and 1 hours before contrast exposure
  • Diphenhydramine 50 mg PO 1 hour before exposure
  • Some centers add an H2 blocker (famotidine 20 mg) at the 1-hour point

Accelerated inpatient regimen (urgent, when full 13-hour prep isn’t possible)

  • Hydrocortisone 200 mg IV immediately and every 4 hours until contrast
  • Diphenhydramine 50 mg IV 1 hour before
  • This is suboptimal — true reduction in reaction severity is less than the full outpatient regimen

Use of a different agent

In patients with prior moderate or severe reactions to a specific contrast agent, consider using a different agent if possible. For example, if a patient had a severe reaction to iohexol, iopamidol or iodixanol are reasonable alternatives. Cross-reactivity is partial but not complete.

Limits of premedication

Premedication regimens reduce the rate of severe reactions but do not eliminate them. Severe anaphylactoid reactions still occur in 1–2% of premedicated patients with a history. Have epinephrine drawn up before the contrast injection in any patient with a known significant history.

When NOT to premedicate

In emergency situations (acute MI, ongoing stroke, urgent ablation for a hemodynamically unstable arrhythmia), the time required for premedication is not appropriate. Proceed with contrast, have epinephrine drawn up, and treat reactions as they develop. The risk-benefit calculation favors acting.

Contrast extravasation (a separate issue)

Sometimes confused with allergic reaction — contrast that has escaped the vein into surrounding tissue causes pain, swelling, and tenderness at the IV site. Management is local: elevate the limb, warm or cool compresses (institutional preference), monitor for compartment syndrome in large extravasations. Not an allergic reaction; not treated with epinephrine.

Contrast nephropathy — the other problem

Renal injury from contrast is a different mechanism (osmotic, hemodynamic, direct tubular toxicity) and a different timeline (24–48 hours after exposure, not minutes).

Risk factors:

  • Pre-existing kidney disease (eGFR < 60 mL/min/1.73m²)
  • Diabetes mellitus
  • Heart failure
  • Older age
  • Volume depletion
  • Concomitant nephrotoxic agents (NSAIDs, aminoglycosides)

Prevention:

  • IV hydration — isotonic saline at 1–1.5 mL/kg/hour for several hours before and after the procedure
  • Lower contrast volume — use the minimum needed
  • Avoid repeat contrast within 24–48 hours of the prior dose
  • Hold nephrotoxic medications in the peri-procedural window if possible

The N-acetylcysteine and sodium bicarbonate prophylaxis protocols of a decade ago have largely fallen out of favor due to mixed evidence. Hydration remains the mainstay.

Documentation after a reaction

Every contrast reaction in the lab requires:

  • Agent name (e.g., iohexol, iodixanol) and dose
  • Reaction severity classified (mild, moderate, severe)
  • All medications administered with doses and times
  • Outcome — full recovery, observation, escalation
  • Allergy band placed before discharge with the specific agent and severity
  • Patient counseling on future contrast exposures — they may need different agents or premedication next time
  • Referral to allergy for moderate/severe reactions to clarify mechanism and confirm cross-reactivity profile

The next provider needs to know exactly what happened. Document specifically — “Allergic reaction” without the agent name and severity is not useful.

Last reviewed by Dr. Colombowala on May 24, 2026.

Clinical-reference content, not medical advice. This page is written for EP staff and does not create a doctor-patient relationship. It does not replace institutional policy, current device manuals, or attending direction during a case. See the full disclaimer.

© 2026 Ilyas K. Colombowala, MD. All rights reserved. Reproduction, redistribution, or republication of this content in any form without written permission is prohibited.

Source: